Showing results (71-80 of 2,459) with videos related to
Sort By:
Pageof 246
Current Opinion in HIV and AIDS|September 24, 2016
Modeling HIV vaccine trials of the futurePeter B Gilbert, Ying Huang, Holly E JanesLifetime Data Analysis|May 8, 2004
Tests for comparing mark-specific hazards and cumulative incidence functionsPeter B Gilbert, Ian W McKeague, Yanqing SunMedrxiv : the Preprint Server for Health Sciences|January 27, 2021
Evaluating the Long-Term Efficacy of COVID-19 VaccinesDan-Yu Lin, Donglin Zeng, Peter B GilbertBiometrics|July 5, 2007
Genome scanning tests for comparing amino acid sequences between groupsPeter B Gilbert, Chunyuan Wu, David V JobesJournal of the American Statistical Association|January 6, 2009
Sensitivity Analyses Comparing Time-to-Event Outcomes Existing Only in a Subset Selected PostrandomizationBryan E Shepherd, Peter B Gilbert, Thomas LumleyBiometrics|September 21, 2006
A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trialDevan V Mehrotra, Xiaoming Li, Peter B GilbertClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2021
Evaluating the Long-term Efficacy of Coronavirus Disease 2019 (COVID-19) VaccinesDan-Yu Lin, Donglin Zeng, Peter B GilbertAnnals of Statistics|October 20, 2009
PROPORTIONAL HAZARDS MODELS WITH CONTINUOUS MARKSYanqing Sun, Peter B Gilbert, Ian W McKeagueStatistica Sinica|August 17, 2013
Quantile Regression for Competing Risks Data with Missing Cause of FailureYanqing Sun, Huixia Judy Wang, Peter B GilbertStatistics in Medicine|July 18, 2019
Assessing pharmacokinetic marker correlates of outcome, with application to antibody prevention efficacy trialsPeter B Gilbert, Yuanyuan Zhang, Erika Rudnicki, et al.Pageof 246